Erik Klok, MD, PhD, FESC

Leiden University Medical Center

Prof. F.A. (Erik) Klok is a board-certified specialist in Internal Medicine, with a specialty in vascular medicine in the Leiden University Medical Center (Leiden, the Netherlands) and holds a position as visiting professor at the Center for thrombosis and Hemostasis in Mainz (Germany). This allows him to combine clinical work with scientific activities. His research interests include the diagnosis, treatment and long-term complications of venous thromboembolism.

Presentation(s):

• SSC 01.3 - VTE information toolbox

  Saturday, June 22, 2024
  14:45 – 14:55 ICT

• SOA 04.4 - Acute interventional management in VTE (UIP joint session)

  Sunday, June 23, 2024
  08:00 – 09:15 ICT

• OC 16.3 - Distinct proteomic profiles after remission of Cushing syndrome, but coagulation-related proteins remained abnormal

  Sunday, June 23, 2024
  10:00 – 10:15 ICT

• PB0420 - Study protocol for the DISTINCT trial: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCement.

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0003 - Time trends in vitamin K antagonist (VKA) treatment in the Netherlands in an era of transition to DOACs and lowering of VKA target intensity

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0365 - Use of magnetic resonance direct thrombus imaging for diagnostic management of suspected thrombosis in routine clinical practice

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 23.1 - Clinical outcomes and use of antithrombotic therapy in patients with peripheral artery disease with incident venous thromboembolism: a Dutch nationwide cohort study

  Sunday, June 23, 2024
  14:45 – 15:00 ICT

• SSC 12.13 - Clinical endpoints for acute intervention

  Sunday, June 23, 2024
  17:55 – 18:05 ICT

• PB0943 - Clinical characteristics and mortality of older patients diagnosed with acute pulmonary embolism on the emergency department, compared to other older patients in the emergency department

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0920 - Cost-effectiveness of follow-up algorithms for chronic thromboembolic pulmonary hypertension in pulmonary embolism survivors

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0918 - Outcomes of chronic thromboembolic pulmonary hypertension with or without prior venous thromboembolism

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0929 - Treatment of acute pulmonary embolism in older patients: focus on deviations from guideline recommendation for home treatment and reperfusion treatment

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 42.1 - Optimizing the InShape algorithm for non-invasive exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape IV study

  Monday, June 24, 2024
  14:45 – 15:00 ICT

• OC 53.2 - External Validation of the AF-BLEED Score in Predicting Major Bleeding in Patients with Newly Diagnosed Atrial Fibrillation

  Tuesday, June 25, 2024
  09:45 – 10:00 ICT

• PB0983 - Frequency of discontinuation of vitamin K antagonists and occurrence of bleeding and thromboembolic events in long-term users with a limited life expectancy

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1408 - Incidence and determinants of venous thromboembolic and bleeding complications in patients with hepatocellular carcinoma – the Tityos study

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB0989 - Performance of Risk Scores in Predicting Major Bleeding in LVAD Recipients

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1412 - Thromboembolic and bleeding events and use of antithrombotic therapy in patients with advanced cancer: a Dutch nationwide cohort study from the SERENITY consortium

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1409 - Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in cancer patients

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB0981 - Vitamin K antagonist treatment quality in the last year of life: a multicentre observational cohort

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 64.5 - Antithrombotic therapy and its discontinuation in patients with cancer during their last phase of life: a primary care cohort study from the SERENITY consortium

  Tuesday, June 25, 2024
  15:45 – 16:00 ICT

• OC 70.3 - Exercise capacity in dyspneic persons with a recent acute pulmonary embolism

  Wednesday, June 26, 2024
  10:45 – 11:00 ICT

• OC 74.3 - Development of a new disease-specific health-related quality of life questionnaire for deep vein thrombosis

  Wednesday, June 26, 2024
  10:45 – 11:00 ICT

• OC 74.5 - Exercise capacity, dyspnoea and health-related quality of life six months after rehabilitation in patients with persistent dyspnoea following pulmonary embolism

  Wednesday, June 26, 2024
  11:15 – 11:30 ICT